Digitisation | August 16, 2023
Cipla launches knowledge sharing platform ‘Ciplamed 2.0’
CiplaMed 2.0 leverages advanced analytics and automation
CiplaMed 2.0 leverages advanced analytics and automation
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
Subscribe To Our Newsletter & Stay Updated
